CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Sep. 30, 2025	Jun. 30, 2025
Current assets:
Cash	$ 27,689	$ 4,441
Prepaid expenses	21,845	15,602
Deposits and other assets	5,034	9,190
Total current assets	54,568	29,233
Property and equipment, net (Note 3)
Total assets	54,568	29,233
Current liabilities:
Accounts payable and accrued expenses	2,629,984	2,764,769
Deferred compensation (Note 4)	1,086,612	1,173,237
Convertible notes payable (Note 5)	1,314,524	2,310,402
Convertible bridge note payable (Note 5)	464,106	454,957
Note payable - related party (Note 5)	440,213	423,053
Demand note payable	25,089
Total current liabilities	5,960,528	7,126,418
Total liabilities	5,960,528	7,126,418
Commitments and contingencies
Bion's stockholders' equity (deficit):
Common stock, no par value, 250,000,000 shares authorized, 57,596,165 and 57,386,476 shares issued, respectively; 56,811,260 and 56,682,167 shares outstanding, respectively
Shares to be issued	1,610,349
Additional paid-in capital	134,335,149	134,677,594.00
Subscription receivable - affiliates (Note 7)		(504,650)
Accumulated deficit	(141,889,031)	(141,307,702)
Total Bion's stockholders’ equity (deficit)	(5,943,533)	(7,134,758)
Noncontrolling interest	37,573	37,573
Total equity (deficit)	(5,905,960)	(7,097,185)
Total liabilities and (deficit)	54,568	29,233
Series A Preferred Stock [Member]
Bion's stockholders' equity (deficit):
Preferred stock, value
Series C Preferred Stock [Member]
Bion's stockholders' equity (deficit):
Preferred stock, value